Metropolitan Life Insurance Company (MetLife)’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,820
| Closed | -$12.8K | – | 865 |
|
|
2024
Q1 | $12.8K | Hold |
1,820
| – | – | ﹤0.01% | 2041 |
|
|
2023
Q4 | $10.3K | Hold |
1,820
| – | – | ﹤0.01% | 2173 |
|
|
2023
Q3 | $8.72K | Hold |
1,820
| – | – | ﹤0.01% | 2269 |
|
|
2023
Q2 | $12.5K | Hold |
1,820
| – | – | ﹤0.01% | 2183 |
|
|
2023
Q1 | $14.2K | Sell |
1,820
-307
| -14% | -$2.39K | ﹤0.01% | 2033 |
|
|
2022
Q4 | $16.2K | Hold |
2,127
| – | – | ﹤0.01% | 2107 |
|
|
2022
Q3 | $17.4K | Hold |
2,127
| – | – | ﹤0.01% | 2092 |
|
|
2022
Q2 | $20.6K | Hold |
2,127
| – | – | ﹤0.01% | 2040 |
|
|
2022
Q1 | $29.8K | Buy |
+2,127
| New | +$29.8K | ﹤0.01% | 1888 |
|
|
2021
Q4 | – | Sell |
-3,598
| Closed | -$80.2K | – | 2803 |
|
|
2021
Q3 | $80.2K | Buy |
+3,598
| New | +$80.2K | ﹤0.01% | 2640 |
|